Plus Therapeutics (PSTV) Insider Trading & Ownership $0.66 +0.01 (+1.38%) As of 11:30 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Plus Therapeutics (NASDAQ:PSTV) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage5.49%Number OfInsiders Buying(Last 12 Months)4Amount OfInsider Buying(Last 12 Months)$82,744.90Number OfInsiders Selling(Last 12 Months)0 Get PSTV Insider Trade Alerts Want to know when executives and insiders are buying or selling Plus Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address PSTV Insider Buying and Selling by Quarter Remove Ads Plus Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/13/2024Richard J HawkinsDirectorBuy4,000$1.50$6,000.00 9/11/2024Howard ClowesDirectorBuy5,000$1.34$6,700.00 9/10/2024Andrew John Hugh Macintyr SimsCFOBuy4,098$1.27$5,204.46 9/10/2024Marc H HedrickCEOBuy8,000$1.23$9,840.00 5/8/2024Andrew John Hugh Macintyr SimsCFOBuy4,902$2.04$10,000.08 5/8/2024Howard ClowesDirectorBuy9,804$2.04$20,000.16 5/8/2024Marc H HedrickCEOBuy12,255$2.04$25,000.20 (Data available from 1/1/2013 forward) PSTV Insider Trading Activity - Frequently Asked Questions Who is on Plus Therapeutics's Insider Roster? The list of insiders at Plus Therapeutics includes Andrew John Hugh Macintyr Sims, Greg Petersen, Howard Clowes, Marc H Hedrick, Richard J Hawkins, and Robert P Lenk. Learn more on insiders at PSTV. What percentage of Plus Therapeutics stock is owned by insiders? 5.49% of Plus Therapeutics stock is owned by insiders. Learn more on PSTV's insider holdings. Which Plus Therapeutics insiders have been buying company stock? The following insiders have purchased PSTV shares in the last 24 months: Andrew John Hugh Macintyr Sims ($15,204.54), Greg Petersen ($34,000.00), Howard Clowes ($49,780.15), Marc H Hedrick ($34,840.20), Richard J Hawkins ($6,000.00), and Robert P Lenk ($20,732.50). How much insider buying is happening at Plus Therapeutics? Insiders have purchased a total of 91,947 PSTV shares in the last 24 months for a total of $160,557.39 bought. Which Plus Therapeutics insiders have been selling company stock? The following insider sold PSTV shares in the last 24 months: Marc H Hedrick ($4,053.28). How much insider selling is happening at Plus Therapeutics? Insiders have sold a total of 2,068 Plus Therapeutics shares in the last 24 months for a total of $4,053.28 sold. Plus Therapeutics Key ExecutivesDr. Marc H. Hedrick M.B.A. (Age 61)M.D., President, CEO & Director Compensation: $945.34kMr. Andrew J. Sims CPA (Age 51)VP of Finance & CFO Compensation: $498.51kDr. Norman D. LaFrance FACNP (Age 76)FACP, M.D., Chief Medical Officer & Senior VP Compensation: $646.02kMs. Desiree Smith (Age 60)Corporate Controller, Principal Financial & Accounting Officer Dr. John K. Fraser (Age 63)Chief Scientist More Insider Trading Tools from MarketBeat Related Companies XAIR Insider Ownership QTI Insider Ownership VVOS Insider Ownership LFWD Insider Ownership PETV Insider Ownership IRIX Insider Ownership NMTC Insider Ownership ALUR Insider Ownership ICU Insider Ownership SSKN Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Beware of BigBear.ai: Insiders Are Selling—Should You?XPO Buying $50 Million of Its Own Stock: Here's Why Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or HoldJoby Aviation: Operational Momentum vs. Market SentimentMicroStrategy Sees Insider Buy-Sell Action in Q1 This page (NASDAQ:PSTV) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Plus Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Plus Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PSTV Stock Free PSTV Stock Alerts